Canine parvovirus

From WikiMD's WELLNESSPEDIA

File:CPV pozitif.jpg
A positive test result for Canine Parvovirus

Canine Parvovirus (CPV) is a highly contagious viral disease that affects dogs, particularly puppies between six weeks and six months old. The virus is known for causing severe gastrointestinal distress and can be fatal if not treated promptly.

Virology[edit]

Canine Parvovirus is a member of the Parvoviridae family, which are small, non-enveloped viruses with a single-stranded DNA genome. The virus is highly resistant to environmental factors and can survive for long periods outside a host, making it particularly challenging to control.

Transmission[edit]

The virus is primarily spread through direct contact with an infected dog or through contact with contaminated feces, environments, or objects. It can also be transmitted via the hands, clothing, and shoes of people who have handled infected dogs.

Symptoms[edit]

Infected dogs typically exhibit symptoms such as severe vomiting, diarrhea (often bloody), lethargy, and loss of appetite. The virus attacks rapidly dividing cells, primarily affecting the intestinal tract and bone marrow, leading to severe dehydration and immunosuppression.

Diagnosis[edit]

Diagnosis of Canine Parvovirus is usually based on clinical signs and confirmed through laboratory tests such as ELISA, PCR, or hemagglutination tests. The image on the right shows a positive test result for CPV.

Treatment[edit]

There is no specific antiviral treatment for Canine Parvovirus. Supportive care, including intravenous fluids, anti-nausea medications, and antibiotics to prevent secondary infections, is critical. Early and aggressive treatment significantly improves the chances of survival.

Prevention[edit]

Vaccination is the most effective way to prevent Canine Parvovirus. Puppies should receive a series of vaccinations starting at six to eight weeks of age, with boosters every three to four weeks until they are 16 weeks old. Adult dogs should receive regular booster vaccinations as recommended by their veterinarian.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.